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Resumen Caracterización molecular de cepas de influenza A (H1N1) 2009 de casos leves y graves 














































Samples	 collected	 included:	 50	 nasal	 swabs	 containing	
H1N1pdm	and	50	virus	 isolates.	Severe	cases	were	defined	





RNA	was	isolated	using	trireagent (Molecular research 
Center,	Cincinnati,	OH,	USA).	DNA	was	removed	from	RNA	
preparations	by	 treatment	with	DNase	 I	 (DNA-free,	Ambion,	
Austin,	TX,	USA).	Reverse	transcription	(RT)	reactions	were	
performed	 using	 the	 Superscript	 II	 Reverse	 Transcriptase	
(Invitrogen,	Carlsbad,	CA,	USA).
Two	 protocols	 were	 used	 to	 amplify	 template	 for	 454	
pyrosequencing	 (Roche	 Life	 Sciences,	 CT,	 USA).	 In	 one	
protocol,	 first	 strand	 synthesis	was	 initiated	with	 a	 random	
octamer	linked	to	an	specific	artificial	primer	sequence	known	
as	 the	 sequence	 independent	 amplification	 (SIA)	 primer4; a 
modified	protocol	was	also	used	wherein	first	strand	synthesis	
was	initiated	with	the	SIA	primer	doped	with	a	primer	mixture	
containing	 the	 same	 specific	 sequence	 linked	 to	 influenza	
virus	 A	 (FLUAV),	 influenza	 virus	 B	 (FLUBV)	 and	 influenza	
virus	C	(FLUCV)	sequences	representing	the	conserved	ter-
mini	of	 influenza	virus	genome	segments5.	Random	libraries	
prepared	 with	 this	method	 were	 pyrosequenced.	 The	 raw	




Alternatively,	 random	 primed	 cDNA	were	 amplified	with	
primers	 spanning	 the	whole	 genome	 of	 H1N1pdm	 for	 con-
ventional	 Sanger	 sequencing.	Primers	were	 designed	 using	
SCPrimer	(http://scprimer.cpmc.columbia.edu)6	to	amplify	800	
bp	 regions	 of	 the	H1N1pdm	 genome.	 A	 500	 bp	 staggered	
overlap	 strategy	 was	 employed	 to	 improve	 fidelity	 of	 the	
sequences.	 Terminal	 sequences	were	 added	by	PCR	using	
a	universal	 influenza	A	primer,	 targeting	 the	conserved	viral	
termini	(5’	ATA	TCG	TCT	CGT	ATT	Agt AgA AAC AAg g,)7 
combined	with	 specific	 primers	 positioned	 near	 the	 ends	 of	
the	genome	segments.	Real-time	PCR	SYBR	Green	assays	
(Applied	 Biosystems,	 Foster	 City,	 CA)	 were	 conducted	 to	







For	 the	 clustering	 analysis	we	 performed	 the	Principal	
Component	Analysis	(PCA)	followed	by	consensus	K-means	
clustering.	A	consensus	clustering	out	of	the	1000	individual	
K-means	 trials	 was	 built.	 Parsimony	 tree	 was	 built	 of	 the	
8	concatenated	segments	using	the	dnapars	program	from	
the	 PHYLIP	 package8.	 Clusters	 previously	 found	 with	 the	













































be	 resolved	 completely,	we	 cannot	 determine	whether	
there	was	a	single	H1N1pdm	introduction	in	Argentina	or	
several	events	involving	highly	related	viruses.	Interest-


















of	 this	area	that	result	 in	a	change	 in	 the	conformation	
of	 the	domain	 (e.g.	Thr18913),	 result	 in	 changes	 in	 the	
affinity	of	the	receptor-binding	site	and	are	believed	to	be	
responsible	for	human,	swine	or	avian	hosts	adaptation.	









TABLE	1.–	Data for the specimens presented in this study
Sample	 Date	 Age	 Sex	 Location,	Province	 Symptoms	 Sample	 Accession	
7649	 15-Jun	 63	yrs.	 F	 Salta	City,	Salta	 mild	 isolate	 CY047776-83
7785	 15-Jun	 2	mth.	 M	 Unknown,	Buenos	Aires	 severe	 isolate	 CY047784-91
7937	 17-Jun	 Unknown	 Unknown	 L.	Zamora,	Buenos	Aires	 mild	 isolate	 CY047792-99
7953	 17-Jun	 46	yrs.	 F	 Neuquén,	Neuquén	 mild	 isolate	 CY047800-07
7967	 17-Jun	 35	yrs.	 F	 Quilmes,	Buenos	Aires	 mild	 isolate	 CY047808-15
7980	 17-Jun	 25		yrs.	 F	 City	of	Buenos	Aires	 mild	 isolate	 CY047816-23
8019	 18-Jun	 10		yrs.	 F	 City	of	Buenos	Aires	 mild	 isolate	 CY047824-31
8551	 19-Jun	 26		yrs.	 M	 Ezpeleta,	Buenos	Aires	 severe	 isolate	 CY047832-39
8574	 21-Jun	 18	mth.	 F	 C.	Suárez,	Buenos	Aires	 severe	 isolate	 CY047840-47
8673	 19-Jun	 66	yrs.	 F	 Bariloche,	Rio	Negro	 mild	 isolate	 CY047848-55
8989	 21-Jun	 16	yrs.	 F	 Olavarria,	Buenos	Aires	 mild	 isolate	 CY047856-63
8994	 22-Jun	 30	yrs.	 M	 Olavarria,	Buenos	Aires	 mild	 isolate	 CY047864-71
9004	 22-Jun	 12	yrs.	 F	 San	Pedro,	Buenos	Aires	 mild	 isolate	 CY047872-79
9180	 23-Jun	 8	yrs.	 M	 General	Pico,	La	Pampa	 mild	 isolate	 CY047880-87
9333	 20-Jun	 58	yrs.	 F	 Rio	Gallegos,	Santa	Cruz	 mild	 isolate	 CY047888-95
9384	 23-Jun	 20	yrs.	 M	 Neuquén,	Neuquén	 mild	 isolate	 CY047896-03
9452	 22-Jun	 9	mth.	 M	 City	of	Buenos	Aires	 mild	 isolate	 CY047904-11
9576	 23-Jun	 9	mth.	 F	 Unknown,	Buenos	Aires	 severe	 isolate	 CY047912-07
9579	 23-Jun	 5	yrs.	 M	 Unknown,	Buenos	Aires	 severe	 isolate	 CY047920-27
9583	 24-Jun	 5	yrs.	 Unknown	 Unknown,	Buenos	Aires	 severe	 isolate	 CY047928-35
9588	 24-Jun	 1	mth.	 F	 Unknown,	Buenos	Aires	 severe	 isolate	 CY047936-43
9597	 24-Jun	 1	yrs.	 F	 Unknown,	Buenos	Aires	 severe	 isolate	 CY047944-51
9705	 24-Jun	 9	yrs.	 F	 Puerto	Madryn,	Chubut	 mild	 isolate	 CY047952-59
9711	 24-Jun	 36	yrs.	 Unknown	 Ushuaia,	Tierra	del	Fuego	 mild	 isolate	 CY047960-67
9721	 24-Jun	 52	yrs.	 F	 Ushuaia,	Tierra	del	Fuego	 mild	 isolate	 CY047968-75
12295	 27-Jun	 Unknown	 Unknown	 Jujuy,	Jujuy	 mild	 NS*	 CY047752-53
12508	 27-Jun	 Unknown	 Unknown	 Neuquén,	Neuquén	 mild	 NS*	 CY047754-55
13777	 30-Jun	 50	yrs.	 M	 Cipolletti,	Rio	Negro	 mild	 NS*	 CY047756-63
14044	 1-Jul	 Unknown	 Unknown	 Tucumán,	Tucumán	 mild	 NS*	 CY047764-65
14192	 3-Jul	 19	mth.	 Unknown	 Unknown,	Buenos	Aires	 severe	 NS*	 CY047766-67
14332	 3-Jul	 1	mth.	 Unknown	 City	of	Buenos	Aires	 severe	 NS*	 CY047768-69
14591	 3-Jul	 39	yrs.	 M	 S.	Fernando,	Buenos	Aires	 severe	 NS*	 CY047770-71
15765	 6-Jul	 Unknown	 M	 Cipolletti,	Rio	Negro	 mild	 NS*	 CY047772-73
18426	 9-Jul	 48	yrs.	 M	 City	of	Buenos	Aires	 severe	 NS*	 CY047774-75
*NS: nasal swab















TABLE	2.–	Single Nucleotide Polymorphisms (SNPs) used to classify 5 clusters
Locus	 Consensus	 Cluster	1	 Cluster	2	 Cluster	3	 Cluster	4	 Cluster	5
888(PB2)	 C	 *	 *	 *	 *	 T
1711(PB2)	 T	 *	 *	 C	 *	 *
1945(PB2)	 G	 *	 *	 A	 *	 *
603(PB1)	 G	 *	 *	 *	 *	 A
636(PB1)	 G	 *	 *	 A	 *	 *
2000(PB1)	 T	 *	 *	 C	 *	 *
2076(PB1)	 C	 *	 *	 *	 *	 T
936(PA)	 G	 *	 *	 A	 *	 *
1741(PA)	 A	 C	 *	 *	 *	 *
4(HA)	 A	 *	 *	 *	 *	 G
1408(HA)	 T	 C	 C	 C	 *	 *
298(NP)	 A	 G	 G	 *	 *	 *
1118(NP)	 C	 T	 *	 *	 *	 *
1143(NP)	 A	 G	 G	 *	 *	 *
316(NA)	 A	 G	 G	 *	 *	 *
742(NA)	 G	 A	 A	 A	 *	 *
659(NS)	 G	 *	 *	 A	 *	 *
*: no change compared with the consensus
Fig.	1.–	Amino	acid	alignment	(in	one-letter	code)	within	the	influenza	HA	receptor	binding	site	(position	171-	237;	H3	number-
ing).	Positions	that	had	been	implicated	in	receptor	specificity	are	indicated	by	^.	Positions	183,	190,	222,	225,	226,	2279-11, 
13 and 189, 193 and 1959	are	marked.	Positions	with	amino	acid	sequence	changes	are	highlighted.	The	box	over	position	
206	highlights	the	amino	acid	change	in	Cluster	5	HA	segments.	Original	host	and	type	of	receptor	binding	specificity	are	
also	indicated;	Swine	(H)	are	human	isolates	of	influenza	virus	of	swine	origin.
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Fig.	2.–	Phylogenetic	analysis	of	 the	H1N1pdm	sequences	using	the	Maximum	Parsimony	method.	For	building	the	tree	we	
use	the	PHYLIP	package8,	and	for	visualizing	it	we	use	the	Dendroscope	program17.
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